Measles virus infection of the respiratory tract

呼吸道麻疹病毒感染

基本信息

  • 批准号:
    10392993
  • 负责人:
  • 金额:
    $ 40.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-04 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Measles is increasing as a cause of morbidity and mortality worldwide. Measles virus (MeV), the causative agent of measles, is spread by the respiratory route and is one of the most highly infectious viruses of humans with an estimated basic reproductive rate (R0) of 12-18 that drives the need for high levels of population immunity to prevent outbreaks. Measles is a human disease, but macaques can contract measles through contact with humans, develop disease that mimics human measles and have been effectively used for studies of measles pathogenesis. Understanding the extremely efficient airborne transmission of MeV requires knowledge of both the initiation of infection after viral aerosol or droplet contact with the respiratory tract and mechanisms of virus control and release. Respiratory epithelial cells were long assumed to be the first site of MeV infection with subsequent spread to lymphoid tissue. However, investigators using enhanced green fluorescent protein (eGFP)-expressing recombinant reporter MeVs were not able to detect infected respiratory epithelial cells early after infection of macaques or to demonstrate infection from the apical surface of differentiated respiratory epithelial cells in culture and deduced that they had not become infected. Because eGFP-expressing cells were observed after basal infection of cultured epithelial cells, an alternate view emerged that lung epithelial cell infection is initiated through basolateral exposure to infected lymphocytes and does not occur until after the viremia is established. These latter studies have concluded that myeloid cells rather than epithelial cells are the initial sites of MeV infection in the lung. However, our data show that apical infection of respiratory epithelial cells is actually quite efficient, but exposure to MeV induces shedding of MeV- producing multinucleated giant cells from the epithelial surface and leaves it without detectable infected cells. Therefore, epithelial cells may be important for the initiation as well as dissemination of MeV infection. Identification of the susceptible cells in the respiratory tract that allow for very efficient initiation of infection and determination of the mechanism of MeV entry into differentiated epithelial cells are key to understanding efficient MeV transmission and use aerosolized vaccine for measles immunization. To address this critical area we will use in vitro and in vivo studies of rhesus macaques to identify the mechanisms by which both wild type and vaccine strains of MeV infect primary differentiated respiratory tract epithelial cells through the following specific aims: (1) Determine the relative susceptibility to infection with MeV of primary alveolar macrophages and cultures of differentiated cells from the upper and lower respiratory tract that include lung fibroblasts, dendritic cells and basal, ciliated and mucous-producing epithelial cells. (2) Determine the host receptors used and mechanisms by which MeV infects and induces shedding of primary differentiated respiratory epithelial cells after interaction at the apical surface. (3) Identify the innate responses of differentiated respiratory epithelial cells to MeV infection and their role(s) in restricting virus replication.
麻疹正在增加,这是全球发病率和死亡率的原因。麻疹病毒(MEV),原因 麻疹剂是通过呼吸道传播的,是人类最高度感染性的病毒之一 估计的基本生殖率(R0)为12-18,这推动了对高水平人口的需求 防止爆发的免疫力。麻疹是一种人类疾病,但猕猴可以通过 与人类接触,发展模仿人麻疹并有效用于研究的疾病 麻疹发病机理。了解MEV的极其有效的机载传输需要 了解病毒气溶胶后感染的开始或与呼吸道接触的知识 病毒控制和释放的机制。长期以来,呼吸上皮细胞被认为是 MEV感染随后扩散到淋巴组织。但是,调查人员使用增强的绿色 荧光蛋白(EGFP)表达重组记者MEV无法检测到感染的呼吸道 猕猴感染后早期上皮细胞或从 分化的培养中呼吸道上皮细胞,并推断出它们没有被感染。因为 在培养的上皮细胞基础感染后观察到表达EGFP的细胞,这是一种替代视图 出现的是,肺上皮细胞感染是通过基底外侧暴露于感染的淋巴细胞和 直到建立病毒血症之后才发生。这些后者的研究得出的结论是髓样细胞 而不是上皮细胞是肺中MEV感染的初始部位。但是,我们的数据表明顶端 呼吸上皮细胞的感染实际上是非常有效的,但暴露于MEV会引起Mev-的脱落。 从上皮表面产生多核巨细胞,并将其留而没有可检测到的感染细胞。 因此,上皮细胞可能对MEV感染的启动和传播可能很重要。 识别呼吸道中易感细胞,该细胞允许非常有效地感染和 确定MEV进入分化上皮细胞的机制是理解的关键 有效的MEV传播并使用雾化的疫苗进行麻疹免疫。解决这个关键领域 我们将在体外和体内猕猴研究中识别两种野生型的机制 MEV的疫苗菌株通过以下 具体目的:(1)确定用MEV的原发性肺泡巨噬细胞感染的相对敏感性 以及从包括肺成纤维细胞的上和下呼吸道分化细胞的培养物, 树突状细胞和基础,纤毛和粘液产生的上皮细胞。 (2)确定所使用的宿主受体 MEV感染并诱导主要分化呼吸道上皮的机制和机制 在顶部表面相互作用后的细胞。 (3)确定分化呼吸系统的先天反应 MEV感染的上皮细胞及其在限制病毒复制中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Diane E Griffin的其他基金

Measles virus infection of the respiratory tract
呼吸道麻疹病毒感染
  • 批准号:
    10606523
    10606523
  • 财政年份:
    2020
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Measles virus infection of the respiratory tract
呼吸道麻疹病毒感染
  • 批准号:
    10030808
    10030808
  • 财政年份:
    2020
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Measles virus infection of the respiratory tract
呼吸道麻疹病毒感染
  • 批准号:
    10158453
    10158453
  • 财政年份:
    2020
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Physiological and immunological responses to measles vaccine
麻疹疫苗的生理和免疫反应
  • 批准号:
    9756312
    9756312
  • 财政年份:
    2018
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Physiological and immunological responses to measles vaccine
麻疹疫苗的生理和免疫反应
  • 批准号:
    10200638
    10200638
  • 财政年份:
    2018
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Role of CD4 T cells in fatal alphavisus encephalomyelitis
CD4 T 细胞在致死性甲状病毒脑脊髓炎中的作用
  • 批准号:
    9278654
    9278654
  • 财政年份:
    2016
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Role of CD4 T cells in fatal alphavisus encephalomyelitis
CD4 T 细胞在致死性甲状病毒脑脊髓炎中的作用
  • 批准号:
    8690404
    8690404
  • 财政年份:
    2014
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Role of CD4 T cells in fatal alphavisus encephalomyelitis
CD4 T 细胞在致死性甲状病毒脑脊髓炎中的作用
  • 批准号:
    9210128
    9210128
  • 财政年份:
    2014
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Vitamin A-Mediated Protection in Measles
维生素 A 介导的麻疹保护
  • 批准号:
    8449425
    8449425
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
2013 Infections of the Nervous System: Pathogenesis and Worldwide Impact GRC
2013 神经系统感染:发病机制和全球影响 GRC
  • 批准号:
    8589755
    8589755
  • 财政年份:
    2013
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants
项目1:温度和溶剂对电子烟氧化剂影响的转化研究
  • 批准号:
    10665896
    10665896
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Penn State TCORS: Tobacco Product Composition Effects on Toxicity and Addiction
宾夕法尼亚州立大学 TCORS:烟草产品成分对毒性和成瘾性的影响
  • 批准号:
    10665895
    10665895
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC
将接受阿片类药物使用障碍治疗且吸烟的个体转至 SREC
  • 批准号:
    10661301
    10661301
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Development of a Video-based Personal Protective Equipment Monitoring System
基于视频的个人防护装备监控系统的开发
  • 批准号:
    10585548
    10585548
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别:
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation
用新型吸入干粉化疗制剂治疗非小细胞肺肿瘤
  • 批准号:
    10696996
    10696996
  • 财政年份:
    2023
  • 资助金额:
    $ 40.94万
    $ 40.94万
  • 项目类别: